Peter Koulen, Ph.D
Executive Editor
Professor, Department of Basic Medical Science
University of Missouri, USA
Dr. Koulen has a broad background in neuroscience, with specific training and expertise in key research areas. As a postdoctoral fellow at the Max-Planck-Institute for Brain Research and Yale University School of Medicine, he carried out immunochemistry, electrophysiology and pharmacology research leading to seminal discoveries in neuronal signaling pathways. At the University of North Texas, he expanded his research to include drug development and drug target discovery for neurodegenerative disorders including retinal neurodegeneration, Alzheimer’s disease, animal model and diagnostics development. As PI or co-Investigator on several previous university-, foundation- and NIH-funded grants, he laid the groundwork for research developing effective measures of neuroprotection relevant to advancing technology in electrophysiology, imaging, pharmacology, molecular and cell biology, biochemistry and translational research and established and supervised productive core facilities and large multi-user equipment projects. In addition, he successfully administered multiple research projects (e.g. staffing, research protections, budget) some of which had been and still are multi-center programmatic in nature, collaborated with other researchers, and produced several peer-reviewed publications from each project.
Biomedical research and education, neuroscience, pharmacology, ophthalmology, pharmaceuticals, nutraceuticals, cell biology.
Journal of Bioprocessing & Biotechniques received 3351 citations as per Google Scholar report